Peripheral blood DNA methylation analysis reveals epigenetic marks associated with hereditary breast and ovarian cancer risk
A commercial Human HCT116 DKO Methylated DNA from Zymo Research was performed using bisulfite-seq-PCR on an Illumina MiSeq platform for 2X250 cycles.